Skip to main content

ADVERTISEMENT

Sean Hammond, PhD

This post-hoc analysis of two phase 3 studies demonstrates that solriamfetol, an approved treatment for excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea, ...
10/26/2023